(Q35552455)

8 August 2017

1 reference

title

Lung cancer and cyclooxygenase-2 (English)

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

18 March 2024

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

18 March 2024

J. Esteban Castelao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14530048

18 March 2024

Robert D. Bart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14530048

18 March 2024

Costanzo A. DiPerna

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14530048

18 March 2024

Eric M. Sievers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14530048

18 March 2024

Ross M. Bremner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14530048

18 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0003497503003345?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

https://api.elsevier.com/content/article/PII:S0003497503003345?httpAccept=text/plain

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

The Annals of Thoracic Surgery

18 March 2024

published in

1 reference

8 August 2017

volume

76

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

1327-1335

1 reference

8 August 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Lung cancer--time to move on from chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Revisions in the International System for Staging Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Sulindac for polyposis of the colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Primary response genes induced by growth factors and tumor promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

7 January 2021

Cyclooxygenases 1 and 2

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

COX-2 is expressed in human pulmonary, colonic, and mammary tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Expression of cyclooxygenase-2 in prostate carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Is COX-2 inhibition a panacea for cancer prevention?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Indomethacin inhibits the accumulation of tumor cells in mouse lungs and subsequent growth of lung metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 AND p38 mitogen-activated protein kinase pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Aspirin and lung cancer in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

The molecular regulation of apoptosis and implications for radiation oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Induction of apoptosis by cancer chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Intracellular unesterified arachidonic acid signals apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Cyclooxygenase, lipoxygenase and tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Cyclooxygenase-2: a novel target for cancer chemotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Non-steroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 expression via repression of transcription in lung cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900334-5

Expression of cyclooxygenase-2 in human lung carcinoma

7 January 2021

29

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas

18 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas

18 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer

18 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

18 March 2024

39

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

Meloxicam inhibits the growth of non-small cell lung cancer

18 March 2024

40

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

Inhibition of apoptosis during development of colorectal cancer

18 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells

18 March 2024

56

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells

18 March 2024

60

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells

18 March 2024

68

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases

18 March 2024

83

1 reference

https://api.crossref.org/works/10.1016/S0003-4975(03)00334-5

18 March 2024

Identifiers

1 reference

8 August 2017

1 reference